Drugs / Emedastine
last change Nov 2024 re-read 2 minutes ago

Emedastine

also known as Emedastina · Emedastine fumarate

Small molecule targets HRH1 via inhibition

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved EU (EMA) Emadine 1999-01-27 europa.eu

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05318157 Background Mar 2022 → Oct 2024 allergic rhinitis Beijing Tongren Hospital Unknown No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Emedastine ClinicalTrials.gov intervention name — accepted as the source's own label NCT05318157
Known as Emedastina ChEMBL registry synonym — accepted as the source's own label CHEMBL594
Known as Emedastine fumarate ChEMBL registry synonym — accepted as the source's own label CHEMBL594
Action Inhibit “Histamine H1 receptor antagonist” CHEMBL594
Modality Small molecule CHEMBL594
Route Other “Emedastine Difumarate Eye Drops” NCT05318157
Target HRH1 “Histamine H1 receptor antagonist” CHEMBL594